Skip to content

JBIO JBIO Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$6.38M+282%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.14M-12.5%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$1.5M-183%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$228K+90.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$662K+138%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's increase (decrease) in prepaid expense and other assets?
JBIO (JBIO) reported increase (decrease) in prepaid expense and other assets of -$5.44M in Q1 2026.
How has JBIO's increase (decrease) in prepaid expense and other assets changed year-over-year?
JBIO's increase (decrease) in prepaid expense and other assets decreased by 1173.8% year-over-year, from $507K to -$5.44M.
What is the long-term trend for JBIO's increase (decrease) in prepaid expense and other assets?
Over 2 years (2023 to 2025), JBIO's increase (decrease) in prepaid expense and other assets has grown at a 397.8% compound annual growth rate (CAGR), from -$483K to $11.97M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.